# Dexmedetomidine and Outcomes of Cardiac Surgery (DOCS)

> **NCT02237495** · PHASE2,PHASE3 · COMPLETED · sponsor: **Xijing Hospital** · enrollment: 1100 (actual)

## Conditions studied

- Heart Valve Diseases
- Coronary Artery Disease

## Interventions

- **DRUG:** dexmedetomidine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02237495
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-09
- **Primary completion:** 2017-03-01
- **Final completion:** 2018-03
- **Target enrollment:** 1100 (ACTUAL)
- **Last updated:** 2020-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02237495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02237495, "Dexmedetomidine and Outcomes of Cardiac Surgery (DOCS)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02237495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*